Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $21.9000 (-1.48%) ($21.3100 - $22.1300) on Wed. Jun. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.21% (three month average) | RSI | 44 | Latest Price | $21.9000(-1.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -1.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -2% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.105% in a week (0% probabilities). VXX(-34%) TLT(-12%) UNG(-6%) IFRA(-5%) UUP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.105% (StdDev 4.21%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
1 - 5 Day Possible Target | $15.7(-28.31%) | Resistance Level | $23.12 | 5 Day Moving Average | $22.23(-1.48%) | 10 Day Moving Average | $22.66(-3.35%) | 20 Day Moving Average | $23.12(-5.28%) | To recent high | -46.6% | To recent low | 0% | Market Cap | $1.627b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |